Clinical Trial Alert

Nephrology Times:
doi: 10.1097/01.NEP.0000424005.47261.e0
Clinical Trial Alert

    The following is a partial list of new clinical trials recently added to the National Institutes of Health's ClinicalTrials.gov online registry. More information on these trials is available at www.clinicaltrials.gov.

    Back to Top | Article Outline

    • Anemia •

    NCT01690455

    An Observational Study of Mircera in Renal Anemia Correction in Dialyzed Patients During Daily Clinical Practice

    Ages eligible for study: 18 years and older

    Sponsors and collaborators: Hoffmann-La Roche

    Contact: Reference Study ID Number: ML25701

    Phone: 888-662-6728

    Back to Top | Article Outline
    NCT01695746

    An Observational Study of Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) in Stage III-IV Chronic Kidney Disease Patients Not on Dialysis with Renal Anemia

    Ages eligible for study: 18 years to 65 years

    Sponsors and collaborators: Hoffmann-La Roche

    Contact: Reference Study ID Number: ML25476

    Phone: 888-662-6728

    Back to Top | Article Outline
    NCT01695759

    Evaluation of Clinical Efficacy and Immunogenicity of Eritromax, Produced by Lab Blau Pharmaceutical S/A, Compared to the Product Eprex, Produced by the Laboratory Janssen-Cilag, in Patients with Anemia Secondary to Chronic Kidney Disease

    Ages eligible for study: 18 years to 60 years

    Sponsors and collaborators: LAL Clinica Pesquisa e Desenvolvimento Ltda. (LAL Research and Development Clinic)

    Contact: Alexandre Frederico

    Phone: (19) 38716399

    E-mail: alexandre@lalclinica.com.br

    Back to Top | Article Outline
    NCT01693029

    Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa (ACCESS)

    Ages eligible for study: 18 years and older

    Sponsors and collaborators: Sandoz

    Contact: Sandoz Biopharmaceuticals

    Phone: +49-8024-476-0

    Back to Top | Article Outline

    • Chronic Kidney Disease–Mineral and Bone Disorder •

    NCT01696279

    A Comparison of Lanthanum Carbonate and Calcium Carbonate in Children

    Ages eligible for study: 6 months to 17 years

    Sponsors and collaborators: Shire Development LLC

    Contact: Shire Call Center

    Phone: 866-842-5335

    Back to Top | Article Outline
    NCT01694160

    Oral Paricalcitol in Renal Transplant Recipients for Reducing Albuminuria

    Ages eligible for study: 18 years to 70 years

    Sponsors and collaborators: Oslo University Hospital

    Contact: Hallvard Holdaas, MD, PhD

    Phone: 472-307-1247

    E-mail: hallvard.holdaas@oslo-universitetssykehus.no

    Back to Top | Article Outline

    • Diabetes •

    NCT01683409

    A Study to Test Safety and Efficacy of Baricitinib in Participants with Diabetic Kidney Disease

    Ages eligible for study: 18 years and older

    Sponsors and collaborators: Eli Lilly and Company, Incyte Corporation

    Contact: Eli Lilly and Company

    Phone: 877-285-4559

    Back to Top | Article Outline

    • End-Stage Renal Disease •

    NCT01691196

    Inflammation in Peritoneal Dialysis Patients: Effect of Obesity

    Ages eligible for study: 18 years and older

    Sponsors and collaborators: University of Illinois

    Contact: Natalia Litbarg, MD

    Phone: 312-996-7378

    E-mail: nlitbarg@uic.edu

    Contact: Giamila Fantuzzi, PhD

    Phone: 312-413-5398

    E-mail: giamila@uic.edu

    Back to Top | Article Outline
    NCT01691053

    Mineralocorticoid Receptor Antagonists in End-Stage Renal Disease (MiREnDa)

    Ages eligible for study: 18 years and older

    Sponsors and collaborators: Wuerzburg University Hospital, German Federal Ministry of Education and Research, Clinical Trial Center Wuerzburg (CTCW)

    Contact: Fabian Hammer, MD, PhD

    Phone: +49931201, ext. 46380

    E-mail: hammer_f@klinik.uni-wuerzburg.de

    Contact: Christoph Wanner, MD

    Phone: +49931201, ext. 39030

    E-mail: wanner_c@klinik.uni-wuerzburg.de

    Back to Top | Article Outline
    NCT01693354

    Mid-HDF Randomized Controlled Study on Outcome

    Ages eligible for study: 18 years to 85 years

    Sponsors and collaborators: Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi

    Contact: Antonio Santoro, MD

    Phone: +39 0516362430

    E-mail: antonio.santoro@aosp.bo.it

    Back to Top | Article Outline

    • Hypertension •

    NCT01689415

    Renal Denervation Hypertension After Stroke (REHEARSE)

    Ages eligible for study: 18 years and older

    Sponsors and collaborators: Bispebjerg Hospital; Rigshospitalet, Denmark

    Contact: Hanne Christensen, MD, PhD, DMSci

    Phone: 0045 35312754

    E-mail: hanne.krarup.christensen@regionh.dk

    Contact: Line Bentsen

    Phone: 0045 61143723

    E-mail: line.bentsen@regionh.dk

    Back to Top | Article Outline
    NCT01687725

    Renal Denervation in Treatment-Resistant Hypertension

    Ages eligible for study: 18 years to 85 years

    Sponsors and collaborators: University of Erlangen–Nuremberg Medical School

    Contact: Christian Ott, MD

    Phone: 0049-9131-85, ext. 36245

    E-mail: christian.ott@uk-erlangen.de

    Back to Top | Article Outline
    NCT01704170

    Feasibility Study to Evaluate Renal Denervation Using Focused Ultrasound

    Ages eligible for study: 18 years and older

    Sponsors and collaborators: Kona Medical Inc.

    Contact: Stephanie Higie

    E-mail: shigie@konamedical.com

    Back to Top | Article Outline

    • Membranous Nephropathy •

    NCT01180036

    Membranous Nephropathy Trial of Rituximab (MENTOR)

    Ages eligible for study: 18 years to 80 years

    Sponsors and collaborators: Mayo Clinic

    Contact: Mayo Collaborative Group Study Desk

    Phone: 507-266-1047 or 507-255-0231

    E-mail: mncg@mayo.edu

    Back to Top | Article Outline

    • Transplantation •

    NCT01686191

    Genetic Predictors of Renal Function Following Heart Transplantation

    Ages eligible for study: 18 years to 90 years

    Sponsors and collaborators: University of Colorado, Denver; National Jewish Health

    Contact: Christina L Aquilante, PharmD

    Phone: 303-724-6126

    E-mail: christina.aquilante@ucdenver.edu

    Back to Top | Article Outline
    NCT01689272

    Functional Reserve Estimation of Donor Kidney

    Ages eligible for study: 18 years to 60 years

    Sponsors and collaborators: Republican Scientific Center for Emergency Medicine

    Contact: Gani M. Kuttymuratov, PhD

    Phone: +77172702912, ext. +77018812206

    E-mail: aiger2000@mail.ru

    Contact: Kuat P. Oshakbayev, PhD, DSc

    Phone: +77172702905, ext. +77013999394

    E-mail: okp.kuat@mail.ru

    Back to Top | Article Outline
    NCT01709097

    Compliance/Adherence After Kidney Transplant, With or Without Med-O-Wheel

    Sponsors and collaborators: Karolinska University Hospital, Addoz, Roche Pharma AG, Tele2 Sverige AB

    Contact: Jarmo Henriksson, RN

    Phone: +46 8 585 825 64

    E-mail: jarmo.henriksson@karolinska.se

    Back to Top | Article Outline
    NCT01706471

    Safety and Efficacy of the Early Introduction of Everolimus (Certican) With Low Dose of Cyclosporine in de Novo Kidney Recipients After 1 Month of Transplantation

    Ages eligible for study: 18 years to 65 years

    Sponsors and collaborators: Yonsei University

    Contact: Yu Seun Kim, MD

    Phone: +82-2-2228-2115

    E-mail: yukim@yuhs.ac

    Back to Top | Article Outline

    • Miscellaneous •

    NCT01674465

    The Role of Nox2 in CNI-Induced Renal Fibrosis

    Ages eligible for study: 18 years to 70 years

    Sponsors and collaborators: University of Wisconsin–Madison

    Contact: Lynn M. Jacobson

    Phone: 608-265-5489

    E-mail: lmj@medicine.wisc.edu

    Contact: Arjang Djamali, MD, MS

    Phone: 608-265-7593

    E-mail: axd@medicine.wisc.edu

    © 2012 Lippincott Williams & Wilkins, Inc.